SMMT logo

Summit Therapeutics (SMMT) Accounts Receivable

Annual Accounts Receivable

$0.00
-$349.00 K-100.00%

December 31, 2023


Summary


Performance

SMMT Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSMMTbalance sheetmetrics:

Quarterly Accounts Receivable

N/A

September 30, 2024


Summary


Performance

SMMT Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSMMTbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

SMMT Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-100.0%-
3 y3 years-100.0%-
5 y5 years-100.0%-

SMMT Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-100.0%at low
5 y5-year-100.0%at low
alltimeall time-100.0%at low

Summit Therapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
Mar 2023
-
$0.00(-100.0%)
Dec 2022
$349.00 K(-76.2%)
$349.00 K(+149.3%)
Sep 2022
-
$140.00 K(-41.2%)
Jun 2022
-
$238.00 K(-72.6%)
Mar 2022
-
$870.00 K(-40.6%)
Dec 2021
$1.46 M(+342.3%)
$1.46 M(-36.1%)
Sep 2021
-
$2.29 M(+117.5%)
Jun 2021
-
$1.05 M(+135.6%)
Mar 2021
-
$447.00 K(+35.0%)
Dec 2020
$331.00 K(-38.8%)
-
Dec 2020
-
$331.00 K(-91.9%)
Sep 2020
-
$4.08 M(-66.3%)
Mar 2020
-
$12.10 M(+4.7%)
Dec 2019
$541.00 K(-75.1%)
-
Oct 2019
-
$11.55 M(-11.1%)
Jul 2019
-
$12.99 M(+6.2%)
Apr 2019
-
$12.23 M(+463.1%)
Jan 2019
$2.17 M(-86.2%)
-
Jan 2019
-
$2.17 M(-86.2%)
Jan 2018
$15.69 M
-
Jan 2018
-
$15.69 M(+430.5%)
Apr 2015
-
$2.96 M(+38.0%)
Oct 2014
-
$2.14 M(-1.7%)
DateAnnualQuarterly
Jul 2014
-
$2.18 M(+438.0%)
Jul 2013
-
$405.40 K(+403.0%)
Jan 2013
$80.60 K(+9.2%)
-
Jan 2013
-
$80.60 K(-70.7%)
Jul 2012
-
$274.90 K(+272.5%)
Jan 2012
$73.80 K(+45.8%)
-
Jan 2012
-
$73.80 K(-90.8%)
Jul 2011
-
$805.80 K(+1492.5%)
Jan 2011
$50.60 K(-22.7%)
-
Jan 2011
-
$50.60 K(-80.7%)
Jul 2010
-
$262.20 K(+300.3%)
Jan 2010
$65.50 K(-93.0%)
-
Jan 2010
-
$65.50 K(-87.6%)
Jul 2009
-
$529.60 K(-43.6%)
Jan 2009
$938.30 K(+149.7%)
-
Jan 2009
-
$938.30 K(-63.9%)
Jul 2008
-
$2.60 M(+592.3%)
Jan 2008
$375.80 K(-32.3%)
-
Jan 2008
-
$375.80 K(-90.0%)
Jul 2007
-
$3.76 M(+576.7%)
Jan 2007
$555.10 K(+141.0%)
-
Jan 2007
-
$555.10 K(+141.0%)
Jan 2006
$230.30 K(+205.8%)
-
Jan 2006
-
$230.30 K(-69.5%)
Jul 2005
-
$754.40 K(+901.9%)
Jan 2005
$75.30 K
-
Jan 2005
-
$75.30 K

FAQ

  • What is Summit Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Summit Therapeutics?
  • What is Summit Therapeutics annual accounts receivable year-on-year change?
  • What is the all time high quarterly accounts receivable for Summit Therapeutics?

What is Summit Therapeutics annual accounts receivable?

The current annual accounts receivable of SMMT is $0.00

What is the all time high annual accounts receivable for Summit Therapeutics?

Summit Therapeutics all-time high annual accounts receivable is $15.69 M

What is Summit Therapeutics annual accounts receivable year-on-year change?

Over the past year, SMMT annual accounts receivable has changed by -$349.00 K (-100.00%)

What is the all time high quarterly accounts receivable for Summit Therapeutics?

Summit Therapeutics all-time high quarterly accounts receivable is $15.69 M